Pfizer News Today - Search News

Activist Investor Starboard Value Takes $1B Stake in Pfizer

Pfizer CEO plans to meet activist investor Starboard Value, FT reports

Pfizer CEO Albert Bourla plans to meet activist investor Starboard Value, the Financial Times reported on Tuesday, citing people familiar with the matter.

The Wall Street Journal on MSN · 12h

Why Pfizer Will Find It Hard to Appease Its Activist Investor

The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.

BioSpace · 19h

Activist Investor Starboard Carves $1B Stake in Pfizer, Enlists Former CEO for Help

Pfizer in recent months has implemented aggressive cost-cutting measures to help it weather the steep decline in sales of its COVID-19 products.

GSK, Pfizer RSV vaccine sales fall in US

Reuters on MSN · 9h

Analysis-GSK, Pfizer RSV vaccine sales fall in US as millions fewer people line up

U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and said it was a once-in-a-lifetime shot for now, excluding millions of people who got one last year.

Pfizer wins bid to invalidate 2 GSK patents relating to RSV vaccine

London: Pfizer recently achieved a significant legal victory by winning bid in a London court to invalidate two patents held by GlaxoSmithKline (GSK) that are related to a vaccine for

U.S. News & World Report · 21h

Pfizer, BioNTech Win Bid to Invalidate CureVac's UK COVID Vaccine Patents

Pfizer and its German partner BioNTech on Tuesday won their attempt to invalidate two of rival CureVac's patents at London's High Court. Pfizer and BioNTech had filed their lawsuit in September 2022 over patents relating to messenger RNA (mRNA) technology,

Pfizer, Arcadium Lithium, Richemont

The Motley Fool · 1d

Why Pfizer Stock Popped on Monday

How Pfizer got itself in a pickle. As the Journal explains, Pfizer bet big on vaccines to protect people from COVID, but as the pandemic waned, so did interest in (and sales of) i

Wall Street Journal · 2d

Stocks to Watch Monday: Pfizer, Arcadium Lithium, Richemont

Activist investor Starboard Value has taken a roughly $1 billion stake in Pfizer and wants the struggling drugmaker to make changes to turn its performance around, [The Wall Street Journal reported](

Barron's on MSN · 1d

These Stocks Are Moving the Most Today: Pfizer, Apple, Amazon, Arcadium Lithium, Tesla, Netflix, Duckhorn, and More

Activist investor Starboard has taken a $1 billion stake in Pfizer, according to a report, Apple and Amazon shares are downgraded, and Rio Tinto approaches Arcadium Lithium about a potential acquisition.

20hon MSN

Pfizer CEO’s Job Is at Risk. A Shot of Discipline Could Help.

As activist Starboard teams up with former Pfizer executives, the pharma giant’s lack of focus is in the spotlight.

27m

Pfizer joins Nvidia under Singapore-backed programme to help start-ups

Pfizer is looking to use AI in a Singapore initiative to shorten the drug discovery process. Read more at straitstimes.com.

FierceBiotech12h

'Ongoing challenges' force Pfizer to scrap oral RSV med from ReViral buyout

In another blow to its $525 million buyout of ReViral, Pfizer has ended development of sisunatovir, an oral inhibitor ...

FiercePharma14h

Pfizer, bracing for Hurricane Milton, pledges aid to emergency services and health support

Is your company bracing for Milton or working to provide aid in anticipation of the storm? | Pfizer—which opened a global hub ...

22h

Pfizer: A 6% Yielding Ultra SWAN Bargain With Upside Potential

Pfizer (PFE) stock may present opportunities for patient investors. Read how this biotech giant may deliver long-term ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results